893 related articles for article (PubMed ID: 22145509)
21. [Analysis of the risk factors for local recurrence of giant cell tumor of long bone].
Xu H; Niu X
Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):465-8. PubMed ID: 25241792
[TBL] [Abstract][Full Text] [Related]
22. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
[TBL] [Abstract][Full Text] [Related]
23. Treatment of giant-cell tumors of long bones with curettage and bone-grafting.
Blackley HR; Wunder JS; Davis AM; White LM; Kandel R; Bell RS
J Bone Joint Surg Am; 1999 Jun; 81(6):811-20. PubMed ID: 10391546
[TBL] [Abstract][Full Text] [Related]
24. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
25. Management of the giant-cell tumours of the distal radius.
Khan MT; Gray JM; Carter SR; Grimer RJ; Tillman RM
Ann R Coll Surg Engl; 2004 Jan; 86(1):18-24. PubMed ID: 15005940
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance feature of "paintbrush borders" sign as a novel way to predict recurrence of giant cell tumor of bone after curettage: a pilot study.
He Y; Wang J; Zhang J; Du L; Lu Y; Xu J; Yuan F; Tan Y; Ding X
J Int Med Res; 2018 Feb; 46(2):710-722. PubMed ID: 29239274
[TBL] [Abstract][Full Text] [Related]
27. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
[TBL] [Abstract][Full Text] [Related]
28. Functional outcome of en bloc excision and custom prosthetic replacement for giant cell tumor of the distal radius.
Zhang S; Xu MT; Wang XQ; Wang JJ
J Orthop Sci; 2015 Nov; 20(6):1090-7. PubMed ID: 26329932
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P
Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085
[TBL] [Abstract][Full Text] [Related]
31. Treatment of giant cell tumor of long bone.
Shih HN; Chen YJ; Huang TJ; Ho WP; Hsueh S; Hsu RW
Changgeng Yi Xue Za Zhi; 1996 Mar; 19(1):16-23. PubMed ID: 8935370
[TBL] [Abstract][Full Text] [Related]
32. Functional outcome in giant cell tumor of distal radius treated with excision and fibular arthroplasty: a case series.
Barik S; Jain A; Ahmad S; Singh V
Eur J Orthop Surg Traumatol; 2020 Aug; 30(6):1109-1117. PubMed ID: 32358713
[TBL] [Abstract][Full Text] [Related]
33. Multicentric giant cell tumor of bone. Clinicopathologic analysis of thirty cases.
Hoch B; Inwards C; Sundaram M; Rosenberg AE
J Bone Joint Surg Am; 2006 Sep; 88(9):1998-2008. PubMed ID: 16951117
[TBL] [Abstract][Full Text] [Related]
34. What are the Functional Results, Complications, and Outcomes of Using a Custom Unipolar Wrist Hemiarthroplasty for Treatment of Grade III Giant Cell Tumors of the Distal Radius?
Wang B; Wu Q; Liu J; Chen S; Zhang Z; Shao Z
Clin Orthop Relat Res; 2016 Dec; 474(12):2583-2590. PubMed ID: 27422390
[TBL] [Abstract][Full Text] [Related]
35. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution.
Niu X; Zhang Q; Hao L; Ding Y; Li Y; Xu H; Liu W
J Bone Joint Surg Am; 2012 Mar; 94(5):461-7. PubMed ID: 22398741
[TBL] [Abstract][Full Text] [Related]
36. Features of grade 3 giant cell tumors of the distal radius associated with successful intralesional treatment.
Kang L; Manoso MW; Boland PJ; Healey JH; Athanasian EA
J Hand Surg Am; 2010 Nov; 35(11):1850-7. PubMed ID: 20934816
[TBL] [Abstract][Full Text] [Related]
37. Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence.
Kafchitsas K; Habermann B; Proschek D; Kurth A; Eberhardt C
Anticancer Res; 2010 Sep; 30(9):3795-9. PubMed ID: 20944172
[TBL] [Abstract][Full Text] [Related]
38. Curettage with cement augmentation of large bone defects in giant cell tumors with pathological fractures in lower-extremity long bones.
Gupta SP; Garg G
J Orthop Traumatol; 2016 Sep; 17(3):239-47. PubMed ID: 26879890
[TBL] [Abstract][Full Text] [Related]
39. What Happens to the Articular Surface After Curettage for Epiphyseal Chondroblastoma? A Report on Functional Results, Arthritis, and Arthroplasty.
Farfalli GL; Slullitel PA; Muscolo DL; Ayerza MA; Aponte-Tinao LA
Clin Orthop Relat Res; 2017 Mar; 475(3):760-766. PubMed ID: 26831477
[TBL] [Abstract][Full Text] [Related]
40. Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement.
Gao ZH; Yin JQ; Xie XB; Zou CY; Huang G; Wang J; Shen JN
BMC Musculoskelet Disord; 2014 Oct; 15():330. PubMed ID: 25277133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
